Back to Menu
Brain arteriovenous malformation is an abnormal vascular structure formed during embryonic cerebrovascular development, in which high-pressure arterial blood directly drains into the low-pressure venous system without the buffering regulation of an intervening capillary network. Chronic abnormal shunting may lead to venous dilation and vessel wall fragility, thereby increasing the risk of rupture, hemorrhage, and neurological complications.
In clinical practice, the Spetzler–Martin (SM) grading system is commonly used to evaluate brain arteriovenous malformations. This system integrates the following factors:
1. Size of the nidus
2. Whether the lesion is located in eloquent cortex (e.g., motor or language areas)
3. Pattern of venous drainage (superficial or deep)
The resulting grade helps estimate treatment-related risk and informs the selection of observation, microsurgery, endovascular intervention, or radiosurgery.
1. Congenital developmental anomaly: A normal capillary bed fails to form during embryonic cerebrovascular development.
2. Genetic factors: A minority of cases are associated with hereditary hemorrhagic telangiectasia (HHT).
3. Hemodynamic changes: With aging, the nidus may enlarge and remodel, which can influence hemorrhagic risk.
Brain arteriovenous malformation is usually a congenital vascular developmental anomaly and is generally not preventable. However, the following measures may reduce the risk of hemorrhage and other complications and support long-term management:
1. Early recognition: Adolescents and young adults with spontaneous intracranial hemorrhage, recurrent seizures, sudden severe headache, or new neurological deficits should undergo prompt specialist evaluation.
2. Basic risk control: Control blood pressure; in patients with diabetes or hyperlipidemia, maintain stable metabolic parameters and take medications as prescribed.
3. Avoid triggers and use medications cautiously: Minimize the risk of head trauma; avoid stimulants/illicit drugs; anticoagulant or antiplatelet therapy should be balanced under specialist assessment and should not be adjusted without medical advice.
4. Standardized follow-up: Patients with a confirmed diagnosis should attend follow-up visits and imaging surveillance as recommended (commonly MRI/MRA or CTA; if detailed vascular assessment is required, DSA may be considered).
5. Psychological and lifestyle management: Maintain regular routines and emotional stability, and seek psychological support and rehabilitation guidance when needed.
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that the key to managing brain arteriovenous malformation lies in evidence-based grading and individualized decision-making. Through multimodal imaging assessment and MDT-based collaboration, hemorrhagic risk can be reduced while maximizing preservation of neurological function and quality of life.
Brain arteriovenous malformation is an abnormal vascular structure formed during embryonic cerebrovascular development, in which high-pressure arterial blood directly drains into the low-pressure venous system without the buffering regulation of an intervening capillary network. Chronic abnormal shunting may lead to venous dilation and vessel wall fragility, thereby increasing the risk of rupture, hemorrhage, and neurological complications.
In clinical practice, the Spetzler–Martin (SM) grading system is commonly used to evaluate brain arteriovenous malformations. This system integrates the following factors:
1. Size of the nidus
2. Whether the lesion is located in eloquent cortex (e.g., motor or language areas)
3. Pattern of venous drainage (superficial or deep)
The resulting grade helps estimate treatment-related risk and informs the selection of observation, microsurgery, endovascular intervention, or radiosurgery.
1. Congenital developmental anomaly: A normal capillary bed fails to form during embryonic cerebrovascular development.
2. Genetic factors: A minority of cases are associated with hereditary hemorrhagic telangiectasia (HHT).
3. Hemodynamic changes: With aging, the nidus may enlarge and remodel, which can influence hemorrhagic risk.
Brain arteriovenous malformation is usually a congenital vascular developmental anomaly and is generally not preventable. However, the following measures may reduce the risk of hemorrhage and other complications and support long-term management:
1. Early recognition: Adolescents and young adults with spontaneous intracranial hemorrhage, recurrent seizures, sudden severe headache, or new neurological deficits should undergo prompt specialist evaluation.
2. Basic risk control: Control blood pressure; in patients with diabetes or hyperlipidemia, maintain stable metabolic parameters and take medications as prescribed.
3. Avoid triggers and use medications cautiously: Minimize the risk of head trauma; avoid stimulants/illicit drugs; anticoagulant or antiplatelet therapy should be balanced under specialist assessment and should not be adjusted without medical advice.
4. Standardized follow-up: Patients with a confirmed diagnosis should attend follow-up visits and imaging surveillance as recommended (commonly MRI/MRA or CTA; if detailed vascular assessment is required, DSA may be considered).
5. Psychological and lifestyle management: Maintain regular routines and emotional stability, and seek psychological support and rehabilitation guidance when needed.
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that the key to managing brain arteriovenous malformation lies in evidence-based grading and individualized decision-making. Through multimodal imaging assessment and MDT-based collaboration, hemorrhagic risk can be reduced while maximizing preservation of neurological function and quality of life.